ZIMMER BIOMET HOLDINGS, INC. (ZBH) Options Risk Score
Real-time risk analysis for ZBH options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full ZBH options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan ZBH Now — Free →
Is it risky to sell options on ZIMMER BIOMET HOLDINGS, INC. (ZBH) right now?
For a 4-week expiry, ZIMMER BIOMET HOLDINGS, INC. (ZBH) carries an options catalyst-risk score of 100 out of 100 (HIGH). That score is driven by an upcoming earnings report, 10 recent news items, 4 active legal filings and 15 clinical-trial catalysts falling inside the 4-week window. On TickerRisk's scale 70 and above is HIGH, so a known event is scheduled inside this window — selling premium on ZBH here is a bet on that event rather than on time decay. The score measures scheduled event exposure, not which way the stock will move.
ZBH shows an IV Rank of 56, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 39%. IV Rank answers how ZBH options are priced against their own history, which is the starting point for choosing between selling and buying premium.
ZBH reports on 2026-08-05. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer